Karsten Muenstedt
Universitätsklinikum Gießen und Marburg, Klinik für Frauenheilkunde
Papers
2
Total Citations
117
H-Index
2
About
Karsten Muenstedt is a leading gynecologic oncologist whose research has fundamentally advanced the understanding and clinical management of borderline ovarian tumors (BOT). His work centers on refining surgical staging, identifying age-dependent prognostic factors, and improving long-term outcomes for patients with these complex neoplasms. As a key contributor to the large-scale, multi-center Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study, Muenstedt has produced landmark analyses that directly inform clinical practice. His most-cited paper, with 75 citations, revealed critical age-dependent differences in BOT characteristics and prognosis, demonstrating that younger patients exhibit distinct tumor biology and superior survival compared to older cohorts—a finding that has reshaped risk stratification. A second highly influential study (42 citations) systematically evaluated the prognostic impact of individual surgical staging procedures, providing evidence that incomplete staging is a significant negative predictor and clarifying which specific interventions most strongly influence outcomes. By translating rigorous, registry-based data into actionable clinical insights, Muenstedt has helped standardize surgical approaches and personalize surveillance strategies, making him a pivotal figure in optimizing care for women with borderline ovarian tumors.
Research Focus
Key Achievements
Top Papers
- 1
- 2